Somatic KEAP1 mutations were most frequently found in lung adenocarcinoma (LUAD), followed by LUSC and liver hepatocellular carcinoma (LIHC) (Fig. 2c). This evidence concerns the gene KEAP1 and lung adenocarcinoma.